Growth Metrics

Ginkgo Bioworks Holdings (DNA) Net Income towards Common Stockholders: 2020-2025

Historic Net Income towards Common Stockholders for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -$80.8 million.

  • Ginkgo Bioworks Holdings' Net Income towards Common Stockholders fell 43.18% to -$80.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$339.5 million, marking a year-over-year increase of 47.86%. This contributed to the annual value of -$547.0 million for FY2024, which is 38.73% up from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Net Income towards Common Stockholders stood at -$80.8 million for Q3 2025, which was down 33.92% from -$60.3 million recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Net Income towards Common Stockholders peaked at -$54.5 million during Q2 2021, and registered a low of -$1.6 billion during Q4 2021.
  • For the 3-year period, Ginkgo Bioworks Holdings' Net Income towards Common Stockholders averaged around -$152.0 million, with its median value being -$165.9 million (2024).
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Net Income towards Common Stockholders slumped by 3,359.12% in 2021 and then skyrocketed by 89.22% in 2022.
  • Ginkgo Bioworks Holdings' Net Income towards Common Stockholders (Quarterly) stood at -$1.6 billion in 2021, then soared by 89.22% to -$173.1 million in 2022, then decreased by 22.31% to -$211.7 million in 2023, then soared by 49.20% to -$107.5 million in 2024, then slumped by 43.18% to -$80.8 million in 2025.
  • Its last three reported values are -$80.8 million in Q3 2025, -$60.3 million for Q2 2025, and -$91.0 million during Q1 2025.